# Clinical Study of Double-Endoscopic Combined With Minimally Invasive Treatment for Early Gastric Cancer at Clinical Stage T1b

> **NCT06934824** · NA · NOT_YET_RECRUITING · sponsor: **Hebei Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Gastric Cancer Patients Undergoing Minimally Invasive Gastrectomy

## Interventions

- **PROCEDURE:** Sixty patients with early gastric cancer in stage T1bN0-1M0 were divided into Group A-N0 and Group B-N + according to the presence or absence of lymph node metastasis. When the enrolled patients und

## Key facts

- **NCT ID:** NCT06934824
- **Lead sponsor:** Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06934824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06934824, "Clinical Study of Double-Endoscopic Combined With Minimally Invasive Treatment for Early Gastric Cancer at Clinical Stage T1b". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06934824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*